program
Thursday, November 20th, 2014
9:15
Opening of the Symposium
Session I
Non-canonical involvement of ER and mitochondria in neuroprotection and neurodegeneration
Chair person: Barbara Zablocka (Warsaw, Poland)
9:30–10:00
Agnieszka Chacinska, Warsaw, Poland
Biogenesis, transport and degradation of mitochondrial proteins
Biogenesis, transport and degradation of mitochondrial proteins
10:00–10:30
Miguel A. Perez-Pinzon, Miami, USA
Mechanisms of neuroprotection by ischemic preconditioning: synaptic and mitochondrial modifications
Mechanisms of neuroprotection by ischemic preconditioning: synaptic and mitochondrial modifications
10:30–11:00
Coffee break
11:00–11:30
Katarzyna Piwocka, Warsaw, Poland
Two faces of ER stress – from cancer to neurodegenerative diseases
Two faces of ER stress – from cancer to neurodegenerative diseases
11:30–12:00
Alexei Verkhratsky, Manchester, UK
Astrocytes ER Ca2+ signalling and its pathological relevance
Astrocytes ER Ca2+ signalling and its pathological relevance
12:00–13:30
Lunch and poster session
Session II
Environmental toxins – novel insight into cellular and molecular mechanisms of neurotoxicity
Chair person: Lidia Struzynska (Warsaw, Poland)
13.30-14.00
Michal Toborek, Miami, USA
Targeting the gut-brain axis for cerebrovascular toxicity and prometastatic properties of polychlorinated biphenyls
Targeting the gut-brain axis for cerebrovascular toxicity and prometastatic properties of polychlorinated biphenyls
14.00-14.30
Ralf Dringen, Bremen, Germany
Uptake, metabolism and toxicity of metal-containing nanoparticles in brain cells
Uptake, metabolism and toxicity of metal-containing nanoparticles in brain cells
14.30-15.00
Marta Sidoryk-Wegrzynowicz, Cambridge, UK
Impairment of glutamine/glutamate-γ-aminobutyric acid cycle in manganese toxicity in the central nervous system
Impairment of glutamine/glutamate-γ-aminobutyric acid cycle in manganese toxicity in the central nervous system
15.00-15.30
Tomasz Olszowski, Szczecin, Poland
Cadmium as a pro-inflammatory factor. Chosen cadmium neurotoxicity issues
Cadmium as a pro-inflammatory factor. Chosen cadmium neurotoxicity issues
Friday, November 21st, 2014
Session III
Neuropeptides in pathology and therapy in neurological disorders
Chair person: Andrzej W. Lipkowski (Warsaw, Poland)
9:30–10:00
Zafiroula-Iro Georgoussi, Athens, Greece
New mechanisms of GPCRS functions
New mechanisms of GPCRS functions
10:00–10:30
Joanna Mika, Cracow, Poland
The role of opioid peptides under neuropathic pain
The role of opioid peptides under neuropathic pain
10:30–11:00
Coffee break
11:00–11:30
Fred Nyberg, Uppsala, Sweden
Peptides in neurological disorders
Peptides in neurological disorders
11:30–12:00
Aleksandra Misicka, Warsaw, Poland
Peptides in angiogenesis
Peptides in angiogenesis
12:00–13:30
Lunch and poster session
Session IV
Induced neurogenesis: molecular mechanisms and implementation
Chair: Leonora Buzanska (Warsaw, Poland)
13:30–14:00
Zaal Kokaia, Lund, Sweden
Stroke-induced neurogenesis
Stroke-induced neurogenesis
14:00–14:30
Jens Magnusson, Stockholm, Sweden
Dynamics of neurogenesis in adult human brain
Dynamics of neurogenesis in adult human brain
14:30–15:00
Jacek Jaworski, Warsaw, Poland
Modeling brain disease with use of IPS-derived neurons
Modeling brain disease with use of IPS-derived neurons
15:00–15:30
Gary Brook, Aachen, Germany
The growth and regeneration of axons
The growth and regeneration of axons
